Characteristics at baseline | Hypocomplementemia Group(n = 65) | Normal Complement Group(n = 244) | P- value |
---|---|---|---|
Demographic features | |||
 Gender (male), n (%) | 47 (72.3%) | 144 (59.0%) | 0.05 |
 Age of diagnosis, mean ± SD | 55.85 ± 10.89 | 53.05 ± 13.00 | 0.113 |
 Duration of disease (medium months, IQR) | 12 (4, 36) | 12 (6, 48) | 0.131 |
 Allergy history (n, %) | 40 (61.5%) | 125 (51.2%) | 0.139 |
 Number of organs involved (mean ± SD) | 4.88 ± 1.79 | 2.89 ± 1.36 | < 0.001*** |
 IgG4-RD RI, mean ± SD | 15.74 ± 5.78 | 9.64 ± 4.33 | < 0.001*** |
Organ involvement (n%) | |||
 Lymph node | 43 (66.2%) | 88 (36.1%) | < 0.001*** |
 Lacrimal gland | 43 (66.2%) | 111 (45.5%) | 0.003** |
 Submandibular gland | 41 (63.1%) | 101 (41.4%) | 0.001** |
 Pancreas | 33 (50.8%) | 66 (27.1%) | < 0.001*** |
 Lung | 33 (50.8%) | 44 (18.0%) | < 0.001*** |
 Paranasal sinus | 27 (41.5%) | 68 (27.9%) | 0.029* |
 Parotid gland | 22 (33.8%) | 28 (11.5%) | < 0.001*** |
 Bile duct | 20 (30.8%) | 35 (14.3%) | 0.002** |
 Kidney | 12 (18.5%) | 26 (10.7%) | 0.082 |
 Prostate gland | 10 (15.4%) | 10 (4.1%) | 0.0218* |
 Retroperitoneum | 8 (12.3%) | 46 (18.9%) | 0.229 |
 Aorta/artery | 5 (7.7%) | 28 (11.5%) | 0.442 |
 Pituitary | 3 (4.6%) | 7 (2.9%) | 0.443 |
 Gastrointestinal tract | 0 (0.0%) | 4 (1.6%) |  |
 Mediastinum | 3 (4.6%) | 6 (2.5%) | 0.349 |
 Thyroid (Riedel’s) | 3 (4.6%) | 10 (4.1%) | 0.835 |
Serological features | |||
 C3(normal 0.73–1.46 g/L) | 0.54 ± 0.17 | 0.99 ± 0.33 | < 0.001*** |
 C4(normal 0.10–0.40 g/L) | 0.061 ± 0.047 | 0.19 (0.14,0.25) | < 0.001*** |
 WBC(109/L) | 6.67 ± 1.84 | 6.54 (5.58, 7.75) | 0.894 |
 HGB(g/L) | 132.35 ± 18.38 | 134.37 ± 22.07 | 0.508 |
 PLT(109/L) | 215.80 ± 59.00 | 240.30 ± 75.80 | 0.017* |
 EOS(109/L) | 0.39 (0.14,0.69) | 0.19 (0.10,0.33) | 0.001** |
 ESR (mm/H) | 46.34 ± 32.40 | 16 (7, 37) | < 0.001*** |
 hsCRP (mg/L) (normal<  8mg/L) | 2.5 1(0.82, 8.64) | 1.86 (0.64, 5.68) | 0.117 |
 IgG (normal 7.0–17.0 g/L) | 30.92 ± 15.31 | 18.05 ± 8.79 | < 0.001*** |
 IgA (normal 0.7–4.0 g/L) | 1.59 ± 0.78 | 2.36 ± 1.32 | < 0.001*** |
 IgM (normal 0.4–2.3 g/L) | 0.87 ± 0.63 | 0.81 (0.54, 1.23) | 0.132 |
 IgE (KU/L)(normal<60KU/L) | 471.0 (246.75, 880.00) | 222.00 (63.70, 609.00) | < 0.001*** |
 IgG1(normal 490–1140 mg/dL) | 1295.11 ± 539.48 | 907.73 ± 439.79 | < 0.001*** |
 IgG2(normal 150–640 mg/dL) | 666.83 ± 542.76 | 612.56 ± 256.77 | 0.259 |
 IgG3(normal 20–110 mg/dL) | 100.56 ± 80.81 | 50.54 ± 41.23 | < 0.001*** |
 IgG4(normal 80–135 mg/dL) | 2614.13 ± 1915.39 | 547.50 (274.23,1215.50) | < 0.001*** |
 IgG4/IgG | 0.80 ± 0.44 | 0.44 ± 0.34 | < 0.001*** |
 RF positive (n, %) | 20 (n = 57, 35.1%) | 44 (n = 166, 26.5%) | 0.217 |